Certification Rate
99.1%
Very high DOL cert
2026 data Public-data reference Official source
Sarepta Therapeutics, Inc.
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
- DOL LCA filings
- 108
- DOL-certified
- 99.1%
- Median offered wage
- $129,577
Cambridge, MA NAICS: 325412
The DOL filing record for Sarepta Therapeutics, Inc.
U.S. Department of Labor's OFLC discloses 108 Labor Condition Application filings naming Sarepta Therapeutics, Inc. from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Approvals and denials for Sarepta Therapeutics, Inc.
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 78 H-1B petitions naming Sarepta Therapeutics, Inc. through FY2024, and approved nearly every one of them: 100% approved (78 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Sarepta Therapeutics, Inc. is listed in 108 DOL LCA filings, more filings than 98% of employer filers in this extract. DOL certified 99.1% of those LCAs; the median listed offered wage is $129,577. This is not a USCIS approval, hiring, or sponsorship ranking.
- 108
- DOL LCA filings, FY2023–FY2026
- 99.1%
- DOL-certified
- $129,577
- median offered wage
- Top 2%
- of employer filers by volume
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Cambridge, MA.
Sarepta Therapeutics, Inc. LCA outcome mix
108DOL LCA filings on record
Saved on this device only, no account, no email.
Open saved list
Follow this profile's data updates
Updates when the published DOL data vintage changes; this is a feed, not an alert service.
Sarepta Therapeutics, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
108 2321st of 122824 higher than 120,503 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
LCA filing shape · Sarepta Therapeutics, Inc.
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $72,000–$279,000 .
Title concentration
- Senior Engineer, Gene Therapy Upstream Process Development 7 · 6.5% · $106,809
- Senior Manager, Social Media Engagement 6 · 5.6% · $154,000
- Scientist, Bioinformatics 5 · 4.6% · $104,800
- Principal Statistical Programmer 5 · 4.6% · $149,400
- Senior Scientist, Drug Product Development 4 · 3.7% · $140,000
Worksite counties
- CAMBRIDGE CITY, MA 38 · 39.6%
- ANDOVER, MA 20 · 20.8%
- BURLINGTON, MA 12 · 12.5%
- BEDFORD, MA 7 · 7.3%
- FORT BEND, TX 4 · 4.2%
DOL LCA release change
What changed between the two LCA fiscal years
- Sarepta Therapeutics, Inc.'s disclosed H-1B LCA filing count rose from 13 in FY2024 to 27 in FY2025 (+107.7%).
- Sarepta Therapeutics, Inc.'s average disclosed H-1B offered wage fell from $138,231 in FY2024 to $129,436 in FY2025 (-6.4%).
National-scale filing footprint
Sarepta Therapeutics, Inc. has filed 108 LCAs (more volume than 98% of U.S. employer filers in this extract). DOL certification: 99.1%. Worksites span 6 states , led by MA.
Above-prevailing wage posture
On 108 LCAs with comparable offered vs prevailing wages, Sarepta Therapeutics, Inc. averages about 19% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Qualified (Level II) (38.9% of LCA filings).
Avg. Salary
$129,577
Above portal avg
Total Workers
108
Moderate worker count
Compare with another employer filer
Sarepta Therapeutics, Inc. vs a peer vs the national average, from DOL LCA data.
Avg. offered wage$129,577 · 11% higher than Fidelity Technology Group, LLC
This filer
Peer
$116,535
National avg.
$113,357
Certification rate99.1% · about the same as Fidelity Technology Group, LLC
This filer
Peer
99.4%
National avg.
97.7%
Total LCA filings108 · 97% lower than Fidelity Technology Group, LLC
This filer
Peer
3,809
National avg.
17
FY2025 filings are 79% of FY2023
34 completed-year filings in FY2023, 27 in FY2025. The scale spans up to twice the earlier year's count: the midpoint is unchanged and the endpoint is at least doubled.
Wondering how long it takes USCIS to process an H-1B petition for this employer?
See current I-129 processing times →
Salary Analysis
Compensation range for H-1B positions at Sarepta Therapeutics, Inc.
Minimum
$72,000
Maximum
$279,000
Average Salary
$129,577
LCA Filing History
H-1B LCA filing trends from FY2023 to FY2026
FY2023 34 LCA filings · 97.1% DOL-certified · $136,088 avg
FY2024 13 LCA filings · 100% DOL-certified · $138,231 avg
FY2025 27 LCA filings · 100% DOL-certified · $129,436 avg
FY2026 is partial on this extract. Chart shows completed fiscal years only (through FY2025).
Top Occupations
Most frequently listed job titles at Sarepta Therapeutics, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Senior Engineer, Gene Therapy Upstream Process Development | 7 | $106,809 |
| Senior Manager, Social Media Engagement | 6 | $154,000 |
| Scientist, Bioinformatics | 5 | $104,800 |
| Principal Statistical Programmer | 5 | $149,400 |
| Senior Scientist, Drug Product Development | 4 | $140,000 |
| Lead Engineer, QA IT Validation | 4 | $120,000 |
| Senior Manager, Drug Product Manufacturing Science & Tech. | 3 | $155,000 |
| Senior Engineer, QA Validation and Engineering | 3 | $103,000 |
| Scientist I, Quality Control | 3 | $112,000 |
| Scientist I, Early Stage Process Development, Gene Therapy | 3 | $102,000 |
| Research Associate, Gene Therapy | 3 | $72,000 |
| Research Associate II, In Process Analytics | 3 | $76,000 |
| Research Associate II, Gene Therapy Analytical Development | 3 | $82,846 |
| Project Manager, Scientific Business Development | 3 | $126,006 |
| Principal Engineer, Manufacturing Sciences and Technology | 3 | $149,333 |
Geographic Distribution
Where Sarepta Therapeutics, Inc. places H-1B workers across the United States
Nationwide peers near Sarepta Therapeutics, Inc.'s 108-LCA band
Cross-state DOL neighbors for Sarepta Therapeutics, Inc. - LCA filing-count and offered-wage axes, outside MA.
Similar LCA filing volume
Nearest cross-state employer filers by LCA filing count (108 here; floor ≥10 LCA filings).
Similar avg offered wage
Cross-state employer filers with a comparable average listed offered wage ($129,577 here).
Disclaimer: Informational only, not professional advice.
Read with Sarepta Therapeutics, Inc.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
Abbott Diabetes Care, Inc. · MID-BOOK
ABS(total_petitions) peer at 108 LCAs (Δ 0 heavier vs Sarepta Therapeutics, Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
AIR Worldwide Corporation · MID-BOOK
ABS(total_petitions) peer at 108 LCAs (Δ 0 heavier vs Sarepta Therapeutics, Inc.); CERT-SOLID · WAGE-PREMIUM vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
Ann & Robert H. Lurie Children's Hospital of Chicago · MID-BOOK
ABS(total_petitions) peer at 108 LCAs (Δ 0 heavier vs Sarepta Therapeutics, Inc.); CERT-CLEAN · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
BRUHAT Technologies Inc. · MID-BOOK
ABS(total_petitions) peer at 108 LCAs (Δ 0 heavier vs Sarepta Therapeutics, Inc.); CERT-LOCK · WAGE-BELOW vs this page's MID-BOOK · CERT-CLEAN · WAGE-PREMIUM.
Fidelity Technology Group, LLC · LARGEST-distance pole
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Sarepta Therapeutics, Inc.'s MID-BOOK.
MA worksite board · MID-BOOK
Open the MA state board after the ABS peers. Sarepta Therapeutics, Inc. stamps MID-BOOK · CERT-CLEAN inside that worksite mix.
Salary calculator · WAGE-PREMIUM
Sarepta Therapeutics, Inc.'s WAGE-PREMIUM offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Sarepta Therapeutics, Inc. to compare filing volume and offered wages, not USCIS outcomes.
- Sarepta Therapeutics, Inc. filed 108 LCAs in the indexed extract (99.1% certified in-file). That volume ranks higher than 98% of employer filers.
- Compare offered wages and certification rates against 6 same-state filers on the chart above. Jump to compare
- See how other employers in MA rank on LCA filing volume this vintage. MA filers
- Read what an LCA filing records versus a USCIS petition approval. LCA vs petition
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.